These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19762126)

  • 1. Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.
    Cano C; Páez JA; Goya P; Serrano A; Pavón J; Rodríguez de Fonseca F; Suardíaz M; Martín MI
    Eur J Med Chem; 2009 Dec; 44(12):4889-95. PubMed ID: 19762126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues.
    El Fangour S; Balas L; Rossi JC; Fedenyuk A; Gretskaya N; Bobrov M; Bezuglov V; Hillard CJ; Durand T
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1977-80. PubMed ID: 12781177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
    Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
    J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of all-trans anandamide: a substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation.
    Ferreri C; Anagnostopoulos D; Lykakis IN; Chatgilialoglu C; Siafaka-Kapadai A
    Bioorg Med Chem; 2008 Sep; 16(18):8359-65. PubMed ID: 18782671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
    Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
    Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.
    Di Marzo M; Casapullo A; Bifulco G; Cimino P; Ligresti A; Di Marzo V; Riccio R; Gomez-Paloma L
    J Pept Sci; 2006 Sep; 12(9):575-91. PubMed ID: 16534762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel tail-modified anandamide analogs.
    Yao F; Li C; Vadivel SK; Bowman AL; Makriyannis A
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5912-5. PubMed ID: 18723350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
    De Petrocellis L; Melck D; Ueda N; Maurelli S; Kurahashi Y; Yamamoto S; Marino G; Di Marzo V
    Biochem Biophys Res Commun; 1997 Feb; 231(1):82-8. PubMed ID: 9070224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and isolation of anandamide and other endocannabinoids.
    Hanus LO
    Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
    [No Abstract]   [Full Text] [Related]  

  • 13. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
    Palmer JA; Higuera ES; Chang L; Chaplan SR
    Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
    Sridar C; Snider NT; Hollenberg PF
    Drug Metab Dispos; 2011 May; 39(5):782-8. PubMed ID: 21289075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
    Lam FF; Luk PW; Ng ES
    Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
    Wise LE; Shelton CC; Cravatt BF; Martin BR; Lichtman AH
    Eur J Pharmacol; 2007 Feb; 557(1):44-8. PubMed ID: 17217945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.
    Seltzman HH; Fleming DN; Thomas BF; Gilliam AF; McCallion DS; Pertwee RG; Compton DR; Martin BR
    J Med Chem; 1997 Oct; 40(22):3626-34. PubMed ID: 9357529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The elmiric acids: biologically active anandamide analogs.
    Burstein S
    Neuropharmacology; 2008 Dec; 55(8):1259-64. PubMed ID: 18187165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.